Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Liabilities from Discontinued Operations (2018)

Ironwood Pharmaceuticals' Liabilities from Discontinued Operations history spans 1 years, with the latest figure at 15739000.0 for Q4 2018.

  • For Q4 2018, Liabilities from Discontinued Operations changed N/A year-over-year to 15739000.0; the TTM value through Dec 2018 reached 15739000.0, changed N/A, while the annual FY2018 figure was 15739000.0, N/A changed from the prior year.
  • Liabilities from Discontinued Operations for Q4 2018 was 15739000.0 at Ironwood Pharmaceuticals.
  • Across five years, Liabilities from Discontinued Operations topped out at 15739000.0 in Q4 2018 and bottomed at 15739000.0 in Q4 2018.